Towards an inhalative in vivo application of immunomodulating gelatin nanoparticles in horse-related preformulation studies

References

• Beck-Broichsitter M, Gauss J, Packhaeuser C, Lahnstein K, Schmehl T, Seeger W, Kissel T, Gessler T. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model. Int J Pharm 2009; 367(1–2)169–78
   PubMed Web of Science ®Google Scholar
• Bernstein IL. Bronchoalveolar lavage in asthma – “something old, something new …”. J Allergy Clin Immunol 1984; 7(1)22–5
   Google Scholar
• Bourquin C, Anz D, Zwiorek K, Lanz A, Fuchs S, Weigel S, Wurzenberger C, von der Borch P, Golic M, Moder S, et al. Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity. J Immunol 2008; 181(5)2990–8
   PubMed Web of Science ®Google Scholar
• Butz N, Porte C, Courrier H, Krafft MP, Vandamme Th. Reverse water-in-fluorocarbon emulsions for use in pressurized metered-dose inhalers containing hydrofluoroalkane propellants. Int J Pharm 2002; 238(1–2)257–69
   PubMed Web of Science ®Google Scholar
• Coester CJ, Langer K, Von Briesen H, Kreuter J. Gelatin nanoparticles by two step desolvation-a new preparation method, surface modifications and cell uptake. J Microencapsulation 2000; 17(2)187–93
   PubMed Web of Science ®Google Scholar
• Dailey LA, Schmehl T, Gessler T, Wittmar M, Grimminger F, Seeger W, Kissel T. Nebulization of biodegradable nanoparticles: Impact of nebulizer technology and nanoparticle characteristics on aerosol features. J Control Rel 2003; 86(1)131–44
   PubMed Web of Science ®Google Scholar
• Dhand R. New frontiers in aerosol delivery. Respir Care, 2004;49(6):666–77.
   Google Scholar
• Elhissi AMA, Karnam KK, Nesh-Azari MR, Gill HS, Taylor KMG. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers. J Pharm Pharmacol 2006; 58(7)887–94
   PubMed Web of Science ®Google Scholar
• Elhissi AMA, Taylor KMG. Delivery of liposomes generated from proliposomes using air-jet, ultrasonic, and vibrating-mesh nebulisers. J Drug Delivery Sci Technol 2005; 15(4)261–5
   Web of Science ®Google Scholar
• Finlay WH, Roa W, Loebenberg R, 2005. Formulation of powder containing nanoparticles for aerosol delivery to the lungs. Patent Application Publication US 2005019270
   Google Scholar
• Fuchs S, Winter G, Coester C. Ultrasonic resonator technology as a new quality control method evaluating gelatin nanoparticles. J Microencapsul 2010; 27(3)242–52
   PubMed Web of Science ®Google Scholar
• Ghazanfari T, Elhissi A, Ding Z, Taylor K. The influence of fluid physicochemical properties on vibrating-mesh nebulization. Int J Pharm 2007; 339(1–2)103–11
   PubMed Web of Science ®Google Scholar
• Grenha A, Seijo B, Remunan-Lopez C. Microencapsulated chitosan nanoparticles for lung protein delivery. Eur J Pharm Sci 2005; 25(4–5)427–37
   PubMed Web of Science ®Google Scholar
• Hadinoto K, Zhu K, Tan RBH. Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery. Int J Pharm 2007; 341(1–2)195–206
   PubMed Web of Science ®Google Scholar
• Haroon A, Waldrep JC, Dhand R, 2005. Could vibrating mesh/aperture plate nebulizers be used for human Alpha-1 Anti-Proteinase Inhibitor (hA1PI) replacement therapy? Proceedings of American Thoracic Society annual meeting, 20–25 May 2005, San Diego, California
   Google Scholar
• Hoffman AM. Bronchoalveolar lavage: Sampling technique and guidelines for cytologic preparation and interpretation. Vet Clin North Am Equine Pract 2008; 24(2)423–35
   PubMed Web of Science ®Google Scholar
• Horohov DW, Beadle RE, Mouch S, Pourciau SS. Temporal regulation of cytokine mRNA expression in equine recurrent airway obstruction. Vet Immunol Immunopathol 2005; 108(1–2)237–45
   PubMed Web of Science ®Google Scholar
• Jackson KA, Stott JL, Horohov DW, Watson JL. IL-4 induced CD23 (Fc.vepsiln.RII) up-regulation in equine peripheral blood mononuclear cells and pulmonary alveolar macrophages. Vet Immunol Immunopathol 2004; 101(3–4)243–50
   PubMed Web of Science ®Google Scholar
• Jurk M, Vollmer J. Therapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulation. BioDrugs 2007; 21(6)387–401
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Yamamoto H, Takeuchi H, Fujioka S, Hino T. Pulmonary delivery of insulin with nebulized dl-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. J Control Rel 1999; 62(1–2)279–87
   PubMed Web of Science ®Google Scholar
• Keller M. Innovations and perspectives of metered dose inhalers in pulmonary drug delivery. Int J Pharm 1999; 186(1)81–90
   PubMed Web of Science ®Google Scholar
• Kerkmann M, Costa LT, Richter C, Rothenfusser S, Battiany J, Hornung V, Johnson J, Englert S, Ketterer T, Heckl W, et al. Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells. J Biol Chem 2005; 280(9)8086–93
   PubMed Web of Science ®Google Scholar
• Klier J, May A, Fuchs S, Schillinger U, Plank C, Winter G, Gehlen H, Coester C. Immunostimulation of bronchoalveolar lavage cells from recurrent airway obstruction-affected horses by different CpG-classes bound to gelatin nanoparticles. J Microencap 2011; 144: 79–97
   Google Scholar
• Krieg AM. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Disc 2006; 5(6)471–84
   PubMed Web of Science ®Google Scholar
• Kunzle F, Gerber V, Van der Haegen A, Wampfler B, Straub R, Marti E. IgE-bearing cells in bronchoalveolar lavage fluid and allergen-specific IgE levels in sera from RAO-affected horses. J Vet Med 2007; A 54(1)40–7
   Google Scholar
• Lentz YK, Anchordoquy TJ, Lengsfeld CS. Rationale for the selection of an aerosol delivery system for gene delivery. J Aerosol Med 2006; 19(3)372–84
   PubMedGoogle Scholar
• Liu J, Gong T, Fu H, Wang C, Wang X, Chen Q, Zhang Q, He Q, Zhang Z. Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 2008; 356(1–2)333–44
   PubMed Web of Science ®Google Scholar
• Nyambura BK, Kellaway IW, Taylor KMG. Insulin nanoparticles: Stability and aerosolization from pressurized metered dose inhalers. Int J Pharm 2009; 375(1–2)114–22
   PubMedGoogle Scholar
• Purewal TS. Alternative propellants for metered dose inhalers. Aerosol Spray Rep 1998; 37(11/12)20–5
   Google Scholar
• Rytting E, Nguyen J, Wang X, Kissel T. Biodegradable polymeric nanocarriers for pulmonary drug delivery. Expert Opin Drug Delivery 2008; 5(6)629–39
   PubMed Web of Science ®Google Scholar
• Sato H, Ueberreiter K. Surface tension of aqueous gelatin solution. Polym Prepr, Am Chem Soc, Div Polym Chem 1979; 20(1)907–8
   Google Scholar
• Sham JOH, Zhang Y, Finlay WH, Roa WH, Löbenberg R. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung. Int J Pharm 2004; 269(2)457–67
   PubMed Web of Science ®Google Scholar
• Smola M, Vandamme T, Sokolowski A. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. Int J Nanomed 2008; 3(1)1–19
   PubMed Web of Science ®Google Scholar
• Sung JC, Pulliam BL, Edwards DA. Nanoparticles for drug delivery to the lungs. Trends Biotechnol 2007; 25(12)563–70
   PubMed Web of Science ®Google Scholar
• Tseng CL, Su WY, Yen KC, Yang KC, Lin FH. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials 2009; 30(20)3476–85
   PubMed Web of Science ®Google Scholar
• Tseng CL, Wang TW, Dong GC, Wu SYH, Young TH, Shieh MJ, Lou PJ, Lin FH. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting. Biomaterials 2007; 28(27)3996–4005
   PubMed Web of Science ®Google Scholar
• Vafaei S, Purkayastha A, Jain A, Ramanath G, Borca-Tasciuc T. The effect of nanoparticles on the liquid–gas surface tension of Bi2Te3 nanofluids. Nanotechnology 2009; 20(18)185702-1–185702-6
   Web of Science ®Google Scholar
• Vaughn JM, McConville JT, Burgess D, Peters JI, Johnston KP, Talbert RL, Williams ROI. Single dose and multiple dose studies of itraconazole nanoparticles. Eur J Pharm Biopharm 2006; 63(2)95–102
   PubMed Web of Science ®Google Scholar
• Waldrep JC, Dhand R. Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation. Curr Drug Delivery 2008; 5(2)114–19
   PubMedGoogle Scholar
• Zillies JC, Zwiorek K, Hoffmann F, Vollmar A, Anchordoquy TJ, Winter G, Coester C. Formulation development of freeze-dried oligonucleotide-loaded gelatin nanoparticles. Eur J Pharm Biopharm 2008; 70(2)514–21
   PubMed Web of Science ®Google Scholar
• Zwiorek K, Bourquin C, Battiany J, Winter G, Endres S, Hartmann G, Coester C. Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides. Pharm Res 2008; 25(3)551–62
   PubMed Web of Science ®Google Scholar